Literature DB >> 20820985

The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.

Woo Chul Chung1, Sung Hoon Jung, Kang-Moon Lee, Chang Nyol Paik, Jea Wuk Kawk, Ji Han Jung, Min Kyoung Lee, Yun Kyung Lee.   

Abstract

BACKGROUND: The cag pathogenicity island (PAI), a Helicobacter pylori virulence factor, is associated with the pathogenesis of gastric cancer. Matrix metalloproteinase-7(MMP-7) is upregulated in the epithelial cells of gastric cancer. To date, there is limited information available on the role of cag PAI and MMP-7 in precursor lesions. In this study, we aimed to identify virulent H. pylori strains and the expression of MMP-7 in samples of gastric epithelial dysplasia and intramucosal cancer.
METHODS: One hundred and twelve tissues excised by endoscopic mucosal resection, 76 specimens with gastric epithelial dysplasia and 36 with intramucosal cancer, were examined. All tissue samples were paired with surrounding normal epithelial tissue samples. We performed polymerase chain reaction for cagA and cagL in neoplasia and paired normal specimens, and assessed the matrix metalloproteinase (MMP)-7 expression by immunohistochemical staining.
RESULTS: There was a significant difference in the frequencies of cagA or cagL between specimens with gastric dysplasia and those with intramucosal cancer. We confirmed greater expression of MMP-7 immunoreactivity in intramucosal cancers infected with a virulent H. pylori strain.
CONCLUSION: Our results suggest that infection with a virulent H. pylori strain was associated with early-stage gastric cancer and that carcinogenesis was associated with cag PAI-dependent MMP-7 upregulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820985     DOI: 10.1007/s10120-010-0552-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  46 in total

Review 1.  Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection.

Authors:  T Valmaseda Pérez; J P Gisbert; J M Pajares García
Journal:  Rev Esp Enferm Dig       Date:  2001-07       Impact factor: 2.086

2.  Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.

Authors:  R Aihara; E Mochiki; T Nakabayashi; K Akazawa; T Asao; H Kuwano
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

3.  Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice.

Authors:  Xun Cai; Jane Carlson; Calin Stoicov; Hanchen Li; Timothy C Wang; JeanMarie Houghton
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

4.  Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.

Authors:  Ryuusuke Aihara; Erito Mochiki; Yoichi Kamiyama; Tetsuro Ohno; Takayuki Asao; Hiroyuki Kuwano
Journal:  J Surg Oncol       Date:  2006-05-01       Impact factor: 3.454

5.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

6.  Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.

Authors:  Y Adachi; F Itoh; H Yamamoto; K Matsuno; Y Arimura; M Kusano; T Endoh; Y Hinoda; M Oohara; M Hosokawa; K Imai
Journal:  Int J Oncol       Date:  1998-11       Impact factor: 5.650

7.  Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.

Authors:  Tomoko Kitoh; Hideo Yanai; Yuki Saitoh; Youhei Nakamura; Yoshitaka Matsubara; Hideaki Kitoh; Tomoharu Yoshida; Kiwamu Okita
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

Review 9.  Helicobacter pylori persistence: biology and disease.

Authors:  Martin J Blaser; John C Atherton
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.

Authors:  Hiroshi Matono; Yoshinao Oda; Mari Nakamori; Sadafumi Tamiya; Hidetaka Yamamoto; Ryohei Yokoyama; Tsuyoshi Saito; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2008-08-19       Impact factor: 3.466

View more
  8 in total

1.  MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression.

Authors:  Jan Bornschein; Tina Seidel; Cosima Langner; Alexander Link; Thomas Wex; Michael Selgrad; Doerthe Jechorek; Frank Meyer; Elizabeth Bird-Lieberman; Michael Vieth; Peter Malfertheiner
Journal:  Diagn Pathol       Date:  2015-12-12       Impact factor: 2.644

Review 2.  Proteolysis in Helicobacter pylori-Induced Gastric Cancer.

Authors:  Gernot Posselt; Jean E Crabtree; Silja Wessler
Journal:  Toxins (Basel)       Date:  2017-04-11       Impact factor: 4.546

Review 3.  From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response.

Authors:  Vinícius Lima de Souza Gonçalves; Maria Luísa Cordeiro Santos; Marcel Silva Luz; Hanna Santos Marques; Breno Bittencourt de Brito; Filipe Antônio França da Silva; Cláudio Lima Souza; Márcio Vasconcelos Oliveira; Fabrício Freire de Melo
Journal:  World J Clin Oncol       Date:  2022-03-24

Review 4.  Matrix Metalloproteinases in Helicobacter pylori-Associated Gastritis and Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

5.  Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization.

Authors:  M S Krakowiak; J M Noto; M B Piazuelo; D M Hardbower; J Romero-Gallo; A Delgado; R Chaturvedi; P Correa; K T Wilson; R M Peek
Journal:  Oncogene       Date:  2014-05-19       Impact factor: 9.867

Review 6.  Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine.

Authors:  Markus Stein; Paolo Ruggiero; Rino Rappuoli; Fabio Bagnoli
Journal:  Front Immunol       Date:  2013-10-15       Impact factor: 7.561

7.  A CCD-based reader combined with CdS quantum dot-labeled lateral flow strips for ultrasensitive quantitative detection of CagA.

Authors:  Chen Gui; Kan Wang; Chao Li; Xuan Dai; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2014-02-04       Impact factor: 4.703

8.  CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer.

Authors:  Rony K Roy; Michal M Hoppe; Supriya Srivastava; Animesh Samanta; Neel Sharma; Kar Tong Tan; Henry Yang; Dominic C Voon; Brendan Pang; Ming Teh; Naoko Murata-Kamiya; Masanori Hatakeyama; Young-Tae Chang; Wei Peng Yong; Yoshiaki Ito; Khek Yu Ho; Patrick Tan; Richie Soong; Phillip H Koeffler; Khay Guan Yeoh; Anand D Jeyasekharan
Journal:  Oncotarget       Date:  2016-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.